The knockdown of TUG1 or overexpression of miR-145 resulted in a significant reduction in intracellular glutamine consumption, reduced proliferation and migration of ICC cells, and inhibited tumor development. The gene discussed is TUG1; the disease is intrahepatic cholangiocarcinoma.